ArticleAnnals of internal medicine2021

In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.

Zain ChaglaPubMed ↗Publisher ↗

No numbers read from the abstract.